NATURALYTE Liquid Acid 3.0K 3.0Ca- indicated for use in patients undergoing extracorporeal bicarbonate hemodialysis f... — FDA record Z-1371-2022

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date May 31, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
NATURALYTE Liquid Acid 3.0K 3.0Ca- indicated for use in patients undergoing extracorporeal bicarbonate hemodialysis for acute and chronic renal failure Part Number: 08-3301-2
Reason
Alternate Bottle Caps labeled with "Sealed for your Protection" on the foil not qualified for use
Classification
Class II
Recalling firm
Fresenius Medical Care Holdings, Inc.
Quantity
163 cases
Agency-reported status
Ongoing
Source record identifier
Z-1371-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityUDI-DI: (01) 10840861101757 (17) 240331 (10) 22CTAC102 Lot Number: 22CTAC102 Exp Date: 2024-03-31

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Natiowide

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Report date
Jul 20, 2022
Recall initiation date
May 31, 2022
Center classification date
Jul 12, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records